Halothane hepatotoxicity and hepatic free radical metabolism in guinea pigs; The effects of vitamin E

Canadian Journal of Anaesthesia

Volumn 43, Issue 7, 1996, Pages 741-748

  Durak, I ^a   Guven T ^a   Birey, M ^a   Ozturk H S ^a   Kurtipek, O ^b   Yel, M ^c   Dikmen, B ^b   Canbolat, O ^a   Kavutcu, M ^a   Kacmaz M ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b 2nd Neurosurgery Clinic   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

Author keywords

ANAESTHETICS, VOLATILE: halothane toxicity; COMPLICATIONS: hepatic; TOXICITY: hepatic

Indexed keywords

ALPHA TOCOPHEROL; CATALASE; FREE RADICAL; GLUTATHIONE PEROXIDASE; HALOTHANE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ULTRASTRUCTURE; ELECTRON MICROSCOPY; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; GUINEA PIG; LIVER NECROSIS; LIVER TOXICITY; NONHUMAN; PEROXIDATION; PRIORITY JOURNAL;

EID: 9544232503     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03017960     Document Type: Article

References (42)

1. Stock JGL, Strunin L. Unexplained hepatitis following halothane. Anesthesiology 1985; 63: 424-39.
2. Hughes HC, Lang CM. Hepatic necrosis produced by repeated administration of halothane to guinea pigs. Anesthesiology 1972; 36: 466-72.
3. Inman WHW, Mushin WW. Jaundice after repeated exposure to halothane: an analysis of reports to the Committee on Safety of Medicines. BMJ 1974; 1: 5-10.
4. Inman WHW, Mushin WW. Jaundice after repeated exposure to halothane: a further analysis of reports to the Committee on Safety of Medicines. BMJ 1978; 2: 1455-6.
5. Moult PJA, Sherlock S. Halothane-related hepatitis. QJM 1975; 44: 99-114.
6. Lunam CA, Cousins MJ, Hall P de La M. Guinea-pig model of halothane-associated hepatotoxicity in the absence of enzyme induction and hypoxia. J Pharmacol Exp Ther 1985; 232: 802-9.
7. Lunam CA, Hall P de La M, Cousins MJ. The pathology of halothane hepatotoxicity in a guinea-pig model: a comparison with human halothane hepatitis. British Journal of Experimental Pathology 1989; 70: 533-41.
8. Lind RC, Gandolfi AJ, Hall P de la M. The role of oxidative biotransformation of halothane in the guinea pig model of halothane-associated hepatotoxicity. Anesthesiology 1989; 70: 649-53.
9. Kenna JG, Satoh H, Christ DD, Pohl LR. Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane. J Pharmacol Exp Ther 1988; 245: 1103-9.
10. De Groat H, Noll T. Halothane hepatotoxicity: relation between metabolic activation, hypoxia, covalent binding, lipid peroxidation and liver cell damage. Hepatology 1983; 3: 601-6.
11. Gandolfi AJ, Sipes IG, Brown BR Jr. Detection of covalently bound halothane metabolites in the hypoxic rat model for halothane hepatotoxicity. Fundam Appl Toxicol 1981; 1: 255-9.
12. Plummer JL, Beckwith ALJ, Bastin FN, Adams JF, Cousins MJ, Hall P. Free radical formation in vivo and hepatotoxicity due to anesthesia with halothane. Anesthesiology 1982; 57: 160-6.
13. Lind RC, Gandolfi AJ, Sipes IG, Brown BR Jr, Waters SJ. Oxygen concentrations required for reductive defluorination of halothane by rat hepatic microsomes. Anesth Analg 1986; 65: 835-9.
14. McLain GE, Sipes IG, Brown BR Jr. An animal model of halothane hepatotoxicity: roles of enzyme induction and hypoxia. Anesthesiology 1979; 51: 321-6.
15. Van Dyke RA. Hepatic centrilobular necrosis in rats after exposure to halothane, enflurane or isoflurane. Anesth Analg 1982; 61: 812-9.
16. Siegers CP, Frühling A, Younes M. Halothane hepatotoxicity in hyperthyroid rats as compared to the phenobarbitalhypoxia model. Toxicol Appl Pharmacol 1983; 69: 257-64.
17. Ramsammy LS, Josepovitz C, Ling K-Y, Lane BP, Kaloyanides GJ. Failure of inhibition of lipid peroxidation by vitamin E to protect against gentamicin nephrotoxicity in the rat. Biochemical Pharmacology 1987; 36: 2125-32.
18. Wang Y-M, Madanat FF, Kimball JC et al. Effect of vitamin E against adriamycin-induced toxicity in rabbits. Cancer Res 1980; 40: 1022-7.
19. Kappus H, Diplock AT. Tolerance and safety of vitamin E. A toxicological position report. VERIS, the Vitamin E Research & Information Service. LaGrange, Illinois: 1991.
20. Lowry O, Rosenbrough N, Farr L, Rondall R. Protein measurement with the the folin phenol reagent. J Biol Chem 1951; 183: 265-75.
21. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-69.
22. Sun Y, Oberley LW, Li Y. A. simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 479-500.
23. Durak I, Canbolat O, Kavutçu M, Öztürk HS, Yurtarslaný Z. Activities of total, cytoplasmic, and mitochondrial superoxide dismutase enzymes in sera and pleural fluids from patients with lung cancer. Journal of Clinical Laboratory Analysis 1996; 10: 17-20.
24. Aebi H. Catalase. In: Bergmeyer HU (Ed.). Methods of Enzymatic Analysis. New York and London: Academic Press Inc. 1974: 673.
25. Dahle LK, Hill EG, Holman RT. The thiobarbituric acid reaction and the autooxidations of polyunsaturated fatty acid methyl esters. Arch Biochem Biophys 1962 98: 253-61.
26. Lontz RJ. Electron spin resonance analysis of a γ-irradiated single crystal of pentafluoropropionamide. Journal of Chemical Physics 1966; 45: 1339.
27. Rogers MT, Kispert LD. Trifluoromethyl, and other radicals, in irradiated single crystals of trifluoroacetamide. Journal of Chemical Physics 1967; 46: 3193-9.
28. Gut J, Christen U, Huwyler J. Mechanisms of halothane toxicity: novel insights. Pharmacol Ther 1993; 58: 133-55.
29. Cousins MJ, Gourlay GK, Knights KM, Hall P de la M, Lunam CA, O'Brien P. A randomised prospective controlled study of the metabolism and hepatotoxicity of halothane in humans. Anesth Analg 1987; 66: 299-308.
30. Sharp JH, Trudell JR, Cohen EN. Volatile metabolites and decomposition products of halothane in man. Anesthesiology 1979; 50: 2-8.
31. Royston D. Free radicals. Formation, function and potential relevance in anaesthesia. Anaesthesia 1988; 43: 315-20.
32. Sipes IG, Gandolfi AJ, Pohl LR, Krishna G, Brown BR Jr. Comparison of the biotransformation and hepatotoxicity of halothane and deuterated halothane. J Pharmacol Exp Ther 1980; 214: 716-20.
33. Lind RC, Gandolfi AJ, Hall P de la M. Covalent binding of oxidative biotransformation intermediates is associated with halothane hepatotoxicity in guinea pigs. Anesthesiology 1990; 73: 1208-13.
34. Shingu K, Eger EI II, Johnson BH, et al. Hepatic injury induced by anesthetic agents in rats. Anesth Analg 1983; 62: 140-5.
35. Cousins MJ, Sharp JH, Gourlay GK, Adams JF, Haynes WD, Whitehead R. Hepatotoxicity and halothane metabolism in an animal model with application for human toxicity. Anesth Intensive Care 1979; 7: 9-24.
36. Jee RC, Sipes IG, Gandolfi AJ, Brown BR Jr. Factors influencing halothane hepatotoxicity in the rat hypoxic model. Toxicol Appl Pharmacol 1980; 52: 267-77.
37. Lind RC, Gandolfi AJ, Sipes IG, Brown BR Jr. Comparison of the requirements for hepatic injury with halothane and enflurane in rats. Anesth Analg 1985; 64: 955-63.
38. Ross WT Jr, Daggy BP, Cardell RR Jr. Hepatic necrosis caused by halothane and hypoxia in phenobarbital treated rats. Anesthesiology 1979; 51: 327-33.
39. Copin J-C, Ledig M, Tholey G. Almitrine prevents some hypoxia-induced metabolic injury in rat astrocytes. Mol Chem Neuropathol 1993; 20: 97-109.
40. Kirshenbaum LA, Singal PK. Antioxidant changes in heart hypertrophy: significance during hypoxia-reoxygenation injury. Can J Physiol Pharmacol 1992; 70: 1330-5.
41. Kirshenbaum LA, Singal PK. Changes in antioxidant enzymes in isolated cardiac myocytes subjected to hypoxia-reoxygenation. Lab Invest 1992, 67: 796-803.
42. Sato N, Fujii K, Yuge O, Tanaka A, Morio M. Suppressive effect of vitamin E on lipid peroxidation in halothane-administrated guinea pig liver. In Vivo 1992; 6: 503-5.